Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000525894 | SCV000651275 | benign | Mosaic variegated aneuploidy syndrome 2 | 2024-12-12 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV000525894 | SCV001481494 | uncertain significance | Mosaic variegated aneuploidy syndrome 2 | 2019-01-23 | criteria provided, single submitter | clinical testing | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. |
Ambry Genetics | RCV004975665 | SCV005554951 | likely benign | Inborn genetic diseases | 2024-10-02 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV003935493 | SCV004761753 | likely benign | CEP57-related disorder | 2019-02-21 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |